Occupational risk factors

References

• Rehn L. Blasengeschwuelste bei Fuchsinarbeitern. Arch Klin Chur 1895; 50: 588–600
   Google Scholar
• Weisburger JH. Comments on the history and importance of aromatic and heterocyclic amines in public health. Mutat Res 2002; 506–507: 9–20
   PubMed Web of Science ®Google Scholar
• Hueper WC, Wiley F, Wolfe HD. Experimental production of bladder tumors in dogs by administration of (-naphthylamine. J Ind Hyg Toxicol 1938; 20: 46–84
   Google Scholar
• Case RAM, Hosler ME. Tumours of the urinary bladder in workmen engaged in the manufacture and use of certain dyestuff intermediates in the British chemical industry. Part 1, the role of aniline, benzidine, 1-naphthylamine and 2-naphthylamine. Br J Ind Med 1954; 11: 75–104
   PubMedGoogle Scholar
• Case RAM, Pearson JT. Tumours of the urinary bladder in workmen engaged in the manufacture and use of certain dyestuff intermediates in the British chemical industry. Part II. Further considerations of the role of aniline and of the manufacture of auramine and magenta (fuchsin) as possible causative agents. Br J Ind Med 1954; 11: 213–6
   PubMedGoogle Scholar
• Verma DK, Purdham JT, Roels HA. Translating evidence about occupational conditions into strategies for prevention. Occup Environ Med 2002; 59: 205–14
   PubMed Web of Science ®Google Scholar
• Yu MC, Skipper PL, Tannenbaum SR, Chan KK, Ross RK. Arylamine exposures and bladder cancer risk. Mutat Res 2002; 506–507: 21–8
   PubMed Web of Science ®Google Scholar
• Vineis P, Piratsu R. Aromatic amines and cancer. Cancer Causes Control 1997; 8: 346–55
   PubMed Web of Science ®Google Scholar
• Hemstreet GP, Yin S, Ma Z, Bonner RB, Bi W, Rao JY, et al. Biomarker risk assessment and bladder cancer detection in a cohort exposed to benzidine. J Natl Cancer Inst 2001; 93: 427–36
   PubMedGoogle Scholar
• Delclós J, Betancourt O, Marqués F, Tovalín H. Globalización y salud laboral. Arch Prev Riesgos Labor 2003; 6: 4–9
   Google Scholar
• Yaris F, Dikici MF, Sabuncu HH, Yaris E. A case–control study on the etiology of urinary bladder cancer in Istanbul, Turkey. Asian Pacific J Cancer Prev 2006; 7: 591–4
   PubMedGoogle Scholar
• Ruder AM, Fine LJ, Smith DS. National estimates of occupational exposure to animal bladder tumorigens. J Occup Med 1990; 32: 797–805
   PubMedGoogle Scholar
• International Agency for Research on Cancer. Overall evaluation of carcinogenicity to humans. Group 1: carcinogenic to humans [online]. Updated March 2008 [cited April 20, 2008]. Available from: http://monographs.iarc.fr/ENG/Classification/crthgr01.php.
   Google Scholar
• International Agency for Research on Cancer. Overall evaluation of carcinogenicity to humans. Group 2A, 2B: probable or possibly carcinogenic to humans [online]. Updated March 2008 [cited April 20, 2008]. Available from: http://monographs.iarc.fr/ENG/Classification/crthgr01.php.
   Google Scholar
• Dryson E, ‘t Mannetje A, Walls C, McLean D, McKenzie F, Maule M, et al. Case–control study of high risk occupations for bladder cancer in New Zealand. Int J Cancer 2008; 122: 1340–6
   PubMed Web of Science ®Google Scholar
• Negri E, La Vecchia C. Epidemiology and prevention of bladder cancer. Eur J Cancer Prev 2001; 10: 7–14
   PubMed Web of Science ®Google Scholar
• Monson R, Christiani D. Summary of the evidence: occupation and environment and cancer. Cancer Causes Control 1997; 8: 529–31
   PubMed Web of Science ®Google Scholar
• Thériault G, Tremblay C, Cordier S, Gingras S. Bladder cancer in the aluminium industry. Lancet 1984; 1: 947–50
   PubMed Web of Science ®Google Scholar
• Gibbs GW. Mortality of aluminum reduction plant workers, 1950 through 1977. J Occup Med 1985; 27: 761–70
   PubMedGoogle Scholar
• Colt JS, Baris D, Stewart P, Schned AR, Heaney JA, Mott LA, et al. Occupation and bladder cancer risk in a population-based case–control study in New Hampshire. Cancer Causes Control 2004; 15: 759–69
   PubMed Web of Science ®Google Scholar
• Boffetta P, Dosemeci M, Gridley G, Bath H, Moradi T, Silverman D. Occupational exposure to diesel engine emissions and risk of cancer in Swedish men and women. Cancer Causes Control 2001; 12: 365–74
   PubMed Web of Science ®Google Scholar
• Boffetta P, Silverman DT. A meta-analysis of bladder cancer and diesel exhaust exposure. Epidemiology 2001; 12: 125–30
   PubMed Web of Science ®Google Scholar
• Gun RT, Pratt NL, Griffith EC, Adams GG, Bisby JA, Robinson KL. Update of a prospective study of mortality and cancer incidence in the Australian petroleum industry. Occup Environ Med 2004; 61: 150–6
   PubMed Web of Science ®Google Scholar
• Gun RT, Pratt N, Ryan P, Roder D. Update of mortality and cancer incidence in the Australian petroleum industry cohort. Occup Environ Med 2006; 63: 476–81
   PubMed Web of Science ®Google Scholar
• Lewis RJ, Schnatter AR, Drummond I, Murray N, Thompson FS, Katz AM, et al. Mortality and cancer morbidity in a cohort of Canadian petroleum workers. Occup Environ Med 2003; 60: 918–28
   PubMed Web of Science ®Google Scholar
• Blair A, Stewart PA, Zaebst DD, Pottern L, Zey JN, Bloom TF, et al. Mortality of industrial workers exposed to acrylonitrile. Scand J Work Environ Health 1998; 24(Suppl 2)25–41
   PubMed Web of Science ®Google Scholar
• Marsh GM, Gula MH, Youk AO, Cassidy LD. Bladder cancer among chemical workers exposed to nitrogen products and other substances. Am J Ind Med 2002; 42: 286–95
   PubMed Web of Science ®Google Scholar
• Collins JJ, Acquavella JF. Review and meta-analysis of studies of acrylonitrile workers. Scand J Work Environ Health 1998; 24(Suppl 2)71–80
   PubMedGoogle Scholar
• Gaertner RR, Theriault GP. Risk of bladder cancer in foundry workers: a meta-analysis. Occup Environ Med 2002; 59: 655–63
   PubMed Web of Science ®Google Scholar
• Rafnsson V, Sulem P. Cancer incidence among marine engineers, a population-based study (Iceland). Cancer Causes Control 2003; 14: 29–35
   PubMed Web of Science ®Google Scholar
• Marsh GM, Callahan C, Pavlock D, Leviton LC, Talbott EO, Hemstreet G. A protocol for bladder cancer screening and medical surveillance among high-risk groups: the Drake Health Registry experience. J Occup Med 1990; 32: 881–6
   PubMedGoogle Scholar
• Felknor SA, Delclos GL, Lerner SP, Burau KD, Wood SM, Lusk CM, et al. Bladder cancer screening program for a petrochemical cohort with potential exposure to ?-napthylamine. J Occup Environ Med 2003; 45: 289–94
   PubMed Web of Science ®Google Scholar
• Hemstreet GP, III, Yin S, Ma Z, Bonner RB, Bi W, Rao JY, et al. Biomarker risk assessment and bladder cancer detection in a cohort exposed to benzidine. J Natl Cancer Inst 2001; 93: 427–36
   PubMedGoogle Scholar
• Carpenter L, Roman E. Cancer and occupation in women: identifying associations using routinely collected national data. Environ Health Perspect 1999;107(Suppl):299–303.
   PubMedGoogle Scholar
• Ji J, Granstrom C, Hemminki K. Occupation and bladder cancer: a cohort study in Sweden. Br J Cancer 2005; 92: 1276–8
   PubMed Web of Science ®Google Scholar
• Pelucchi C, La Vecchia C, Negri E, Dal Maso L, Franceschi S. Smoking and other risk factors for bladder cancer in women. Prev Med 2002; 35: 114–20
   PubMed Web of Science ®Google Scholar
• Zheng T, Cantor KP, Zhang Y, Lynch CF. Occupation and bladder cancer: a population-based, case–control study in Iowa. J Occup Environ Med 2002; 44: 685–91
   PubMed Web of Science ®Google Scholar
• Silverman DT, Levin LI, Hoover RN, Hartage P. Occupational risks of bladder cancer in the United States. I. White men. J Natl Cancer Inst 1989; 81: 1472–80
   PubMedGoogle Scholar
• Silverman DT, Levin LI, Hoover RN. Occupational risks of bladder cancer in the United States. II. Nonwhite men. J Natl Cancer Inst 1989; 81: 1480–3
   PubMedGoogle Scholar
• Schulz MR, Loomis D. Occupational bladder cancer mortality among racial and ethnic minorities in 21 states. Am J Ind Med 2000; 38: 90–8
   PubMed Web of Science ®Google Scholar
• Cohen SM, Shirai T, Steineck G. Epidemiology and etiology of premalignant and malignant urothelial changes. Scand J Urol Nephrol 2000:205(Suppl):105–15.
   Google Scholar
• Cartwright RA, Gadian T, Garland JB, Bernard SM. The influence of malignant cell cytology on the survival of industrial bladder cancer cases. J Epidemiol Community Health 1981; 35: 35–8
   PubMed Web of Science ®Google Scholar
• Shinka T, Sawada Y, Morimoto S, Fujinaga T, Nakamura J, Ohkawa T. Clinical study on urothelial tumors of dye workers in Wakayama City. J Urol 1991; 146: 1504–7
   PubMed Web of Science ®Google Scholar
• Vineis P, Simonato L. Proportion of lung and bladder cancers in males resulting from occupation: a systematic approach. Arch Environ Health 1991; 46: 6–15
   PubMed Web of Science ®Google Scholar
• Barone-Adesi F, Richiardi L, Merletti F. Population attributable risk for occupational cancer in Italy. Int J Occup Environ Health 2005; 11: 23–31
   PubMed Web of Science ®Google Scholar
• Sorahan T, Hamilton L, Jackson JR. A further cohort study of workers employed at a factory manufacturing chemicals for the rubber industry, with special reference to the chemicals 2-mercaptobenzothiazole (MBT), aniline, phenyl-?-naphthylamine and o-toluidine. Occup Environ Med 2000; 57: 106–15
   PubMed Web of Science ®Google Scholar
• Miyakawa M, Tachibana M, Miyakawa A. Re-evaluation of the latent period of bladder cancer in dyestuff-plant workers in Japan. Int J Urol 2001; 8: 423–30
   PubMed Web of Science ®Google Scholar
• Vineis P, Marinelli D, Autrup H, Brockmoller J, Cascorbi I, Daly AK, et al. Current smoking, occupation, N-acetyltransferase-2 and bladder cancer: a pooled analysis of genotype-based studies. Cancer Epidemiol Biomarkers Prev 2001; 10: 1249–52
   PubMed Web of Science ®Google Scholar
• Vineis P, Landi MT, Caporaso N. Metabolic polymorphisms and the cancer risk: the evaluation of epidemiological studies. Medicina del Lavoro 1992; 83: 557–75
   PubMedGoogle Scholar
• Vineis P, Caporaso N, Cuzick J, Lang M, Malats N, Boffetta P. Genetic susceptibility to cancer: metabolic polymorphisms. IARC Scientific Publ No 148. Lyon: IARC; 1999.
   Google Scholar
• Cascorbi I, Roots I, Brockmuller J. Association of NAT1 and NAT2 polymorphisms to urinary bladder cancer: significantly reduced risk in subjects with NAT1×10. Cancer Res 2001; 61: 5051–6
   PubMed Web of Science ®Google Scholar
• Shinka T, Ogura H, Morita T, Nishikawa T, Fujimaga T, Ohkawa T. Relationship between glutathione S-transferase M1 deficiency and urothelial cancer in dye workers exposed to aromatic amines. J Urol 1998; 159: 380–3
   PubMed Web of Science ®Google Scholar
• Hung RJ, Boffetta P, Brennan P, Malaveille C, Hautefeuille A, Donato F, et al. GST, NAT, SULT1A1, CYP1B1 genetic polymorphisms, interactions with environmental exposures and bladder cancer risk in a high-risk population. Int J Cancer 2004; 110: 598–604
   PubMed Web of Science ®Google Scholar